HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nitya Jayaram-Lindström Selected Research

Amphetamine-Related Disorders (Addiction, Amphetamine)

1/2022The Hypothesis of Subliminal Cue Reactivity in Addiction Revisited: An fMRI Study.
10/2018Cue reactivity and opioid blockade in amphetamine dependence: A randomized, controlled fMRI study.
3/2014Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial.
1/2013Genetic variation of the ghrelin signalling system in individuals with amphetamine dependence.
4/2010Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.
11/2008Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial.
7/2008Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence.
1/2005An open clinical trial of naltrexone for amphetamine dependence: compliance and tolerability.
12/2004Effects of naltrexone on the subjective response to amphetamine in healthy volunteers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nitya Jayaram-Lindström Research Topics

Disease

9Amphetamine-Related Disorders (Addiction, Amphetamine)
01/2022 - 12/2004
9Alcoholism (Alcohol Abuse)
01/2021 - 07/2009
5Substance-Related Disorders (Drug Abuse)
01/2022 - 04/2010
4Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2021 - 04/2010
1Poisoning
08/2022
1Gambling (Pathological Gambling)
02/2021
1Anxiety Disorders (Anxiety Disorder)
01/2021
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2017

Drug/Important Bio-Agent (IBA)

9Pharmaceutical PreparationsIBA
08/2022 - 12/2004
5Amphetamine (Amfetamine)FDA LinkGeneric
01/2021 - 07/2008
5Naltrexone (ReVia)FDA LinkGeneric
10/2018 - 12/2004
2Dopamine (Intropin)FDA LinkGeneric
01/2020 - 12/2015
2Methylphenidate (Ritalin)FDA LinkGeneric
03/2014 - 04/2010
2Acamprosate (Campral)FDA Link
08/2010 - 07/2009
1Prostaglandins AIBA
02/2021
1Anti-Anxiety Agents (Anxiolytics)IBA
01/2021
1Narcotic Antagonists (Opioid Antagonists)IBA
10/2018
1Opioid Analgesics (Opioids)IBA
10/2018
1Prazosin (Minipress)FDA LinkGeneric
01/2017
1Doxazosin (Cardura)FDA LinkGeneric
01/2017
1OSU 6162IBA
12/2015
1Guanfacine (Tenex)FDA LinkGeneric
03/2015
1GhrelinIBA
01/2013
1Cocaine (Cocaine HCl)IBA
04/2010
1Central Nervous System StimulantsIBA
04/2010
1Therapeutic UsesIBA
07/2009

Therapy/Procedure

3Drug Therapy (Chemotherapy)
08/2013 - 01/2005